Tallouzi MO - Search Results

1

COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.

Tallouzi MO, Mathers JM, Moore DJ, Murray PI, Bucknall N, Blazeby JM, Calvert M, Denniston AK. Tallouzi MO, et al. Trials. 2017 Dec 1;18(1):576. doi: 10.1186/s13063-017-2294-8. Trials. 2017. PMID: 29191216 Free PMC article.

2

Cortisol biosynthesis in the human ocular surface innate immune response.

Susarla R, Liu L, Walker EA, Bujalska IJ, Alsalem J, Williams GP, Sreekantam S, Taylor AE, Tallouzi M, Southworth HS, Murray PI, Wallace GR, Rauz S. Susarla R, et al. PLoS One. 2014 Apr 15;9(4):e94913. doi: 10.1371/journal.pone.0094913. eCollection 2014. PLoS One. 2014. PMID: 24736562 Free PMC article.

3

The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol.

Tallouzi MO, Moore DJ, Calvert M, Murray PI, Bucknall N, Denniston AK. Tallouzi MO, et al. Syst Rev. 2016 Feb 13;5:29. doi: 10.1186/s13643-016-0203-y. Syst Rev. 2016. PMID: 26872918 Free PMC article.

4

Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.

Barry RJ, Tallouzi MO, Bucknall N, Mathers JM, Murray PI, Calvert MJ, Moore DJ, Denniston AK. Barry RJ, et al. Among authors: tallouzi mo. Cochrane Database Syst Rev. 2018 Dec 18;12(12):CD012577. doi: 10.1002/14651858.CD012577.pub2. Cochrane Database Syst Rev. 2018. PMID: 30562409 Free PMC article.

5

The Effectiveness of Pharmacological Agents for the Treatment of Uveitic Macular Edema (UMO): A Systematic Review.

Tallouzi MO, Moore DJ, Barry RJ, Calvert M, Mathers J, Murray PI, Denniston AK. Tallouzi MO, et al. Ocul Immunol Inflamm. 2019;27(4):658-680. doi: 10.1080/09273948.2019.1569243. Epub 2019 Feb 27. Ocul Immunol Inflamm. 2019. PMID: 30811272

6

Outcomes important to patients with non-infectious posterior segment-involving uveitis: a qualitative study.

Tallouzi MO, Moore DJ, Bucknall N, Murray PI, Calvert MJ, Denniston AK, Mathers JM. Tallouzi MO, et al. BMJ Open Ophthalmol. 2020 Jul 21;5(1):e000481. doi: 10.1136/bmjophth-2020-000481. eCollection 2020. BMJ Open Ophthalmol. 2020. PMID: 32724858 Free PMC article.

7

Predictors for diabetic retinopathy progression-findings from nominal group technique and Evidence review.

Haider S, Sadiq SN, Lufumpa E, Sihre H, Tallouzi M, Moore DJ, Nirantharakumar K, Price MJ. Haider S, et al. BMJ Open Ophthalmol. 2020 Oct 9;5(1):e000579. doi: 10.1136/bmjophth-2020-000579. eCollection 2020. BMJ Open Ophthalmol. 2020. PMID: 33083555 Free PMC article.

8

Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.

Tallouzi MO, Mathers JM, Moore DJ, Bucknall N, Calvert MJ, Murray PI, Denniston AK; COSUMO Working Group. Tallouzi MO, et al. Ophthalmology. 2021 Aug;128(8):1209-1221. doi: 10.1016/j.ophtha.2021.01.022. Epub 2021 Jan 28. Ophthalmology. 2021. PMID: 33515595

9

Healthcare professionals' views on the most important outcomes for non-infectious uveitis of the posterior segment: A qualitative study.

Tallouzi MO, Moore DJ, Bucknall N, Murray PI, Calvert MJ, Denniston AK, Mathers J. Tallouzi MO, et al. PLoS One. 2023 Nov 17;18(11):e0294117. doi: 10.1371/journal.pone.0294117. eCollection 2023. PLoS One. 2023. PMID: 37976313 Free PMC article.

10

Bilateral Panuveitis and Exudative Retinal Detachments Associated with Alpelisib.

Chong YJ, Azzopardi M, Tallouzi MO, Spooner D, Masood I, Ghosh Y, Sreekantam S. Chong YJ, et al. Among authors: tallouzi mo. Case Rep Oncol. 2022 Aug 3;15(2):713-719. doi: 10.1159/000525772. eCollection 2022 May-Aug. Case Rep Oncol. 2022. PMID: 36157688 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page